Results from a Phase III registrational study suggest that ecopipam has potential as a first-in-class dopamine-1 receptor ...
The Phase III DIAMOND trial met both its primary and secondary endpoints of reducing tics in both children and adult patients ...
Baylen Out Loud star Baylen Dupree has given fans a close-up glimpse at her engagement ring from fiancé Colin Dooley. The TLC ...
Baylen Out Loud star Baylen Dupree has considered undergoing deep brain stimulation as a treatment for her symptoms of ...
Ecopipam showed statistical significance in treating Tourette syndrome versus a placebo for both its primary efficacy ...
In the renewal announcement clip, Dupree's eyes widen as she reacts, "No! No, really?" She then pumps her fist, flashing the ...
Emalex Biosciences’ dopamine blocker led to fewer patients with Tourette syndrome relapsing in a phase 3 trial, setting the ...
In the Phase III trial, 41.9% of pediatric Tourette syndrome patients relapsed after ecopipam treatment, as compared with ...
After a huge fight at Baylen's birthday party, Colin works on rebuilding trust in a new episode of "Baylen Out Loud" airing ...
TLC’s breakout series, Baylen Out Loud, is getting a second season, per a recent press release from the network. The series ...
Emalex Biosciences is eyeing approval for its Tourette syndrome therapy after it achieved its primary and secondary endpoints in a Phase III study. The US company’s central nervous system (CNS ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results